Document is current
Any future updates will be listed below
-
Authors
Sacha, J.
Woitek, F. J.
Pietrasik, A.
Laupp, A.
Gąsecka, A.
Conrad, A.
Pawłowski, T.
Obradovic, D.
Grygier, M.
Haussig, S.
Bielawski, G.
Mierke, J.
Balak, W.
Jellinghaus, S.
Sukiennik, A.
Burzyńska, P.
Witkowski, A.
Warniełło, M.
Rzeszutko, Ł.
Bartuś, S.
Pawlik, A.
Kaczyński, M.
Gil, R.
Kuliczkowski, W.
Reczuch, K.
Protasiewicz, M.
Kleczyński, P.
Wańczura, P.
Gurba, S.
Kochanowska, A.
Łomiak, M.
Skorupski, W.
Zarębiński, M.
Pawluczuk, P.
Włodarczak, S.
Włodarczak, A.
Ściborski, K.
Telichowski, A.
Pluciński, M.
Hiczkiewicz, J.
Konsek, K.
Hawranek, M.
Gąsior, M.
Peruga, J.
Fiutowski, M.
Romanek, R.
Kasprzyk, P.
Ciećwierz, D.
Ochała, A.
Wojakowski, W.
Legutko, J.
Linke, A.
Kochman, J.
Mangner, N.
- License Information
-
More Information
Article History
Received: 20 July 2025
Accepted: 13 March 2026
First Online: 30 March 2026
Declarations
:
: J.S. is an Impella proctor and has received consulting fees from Abiomed / Johnson & Johnson. A.P. Principal Investigator of the Impella-PL Registry, has received an unrestricted educational grant from Abiomed and has served on the speakers bureau for Abiomed. J.L. has received consulting fees from Abiomed / Johnson & Johnson. A.L. reports honoraria or consultancy fees from Edwards Lifesciences, Boston Scientific, Abiomed, Novartis, Pfizer, Astra Zeneca, Boehringer, Abbott, MSD, Corvia, Daiichi and Meril; received grant support form Edwards Lifesciences and Novartis, and owns stock options from Transverse Medical, Picardia and Filterlex. N.M. has received an educational and research grant from Abiomed to his institution, outside the submitted work; has received an educational grant from Boston Scientific to his institution, outside the submitted work; and has received personal fees from Abbott, Abiomed, Amgen, AstraZeneca, B. Braun, Biotronik, Boston Scientific, Cordis, Edwards Lifesciences, Inari, Medtronic, Pfizer/BMS, and Shockwave, outside the submitted work. Other authors declare no competing interests.
